Inhibition of vascular epoprostenol (prostacyclin, PGI2) production in vitro by plasma from healthy subjects and patients with severe renal impairment.
D000328:Adult; D001011:Aorta / Q000378:metabolism; D001790:Blood Physiological Phenomena; D001808:Blood Vessels / Q000378:metabolism*; D011464:Epoprostenol / Q000096:biosynthesis*; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007674:Kidney Diseases / Q000097:blood*; D008297:Male; D008875:Middle Aged; D011453:Prostaglandins / Q000096:biosynthesis*; D011460:Prostaglandins F / Q000096:biosynthesis; D012709:Serum Albumin / Q000502:physiology
D011453:Prostaglandins; D011460:Prostaglandins F; D012709:Serum Albumin; D011464:Epoprostenol; C100006:prostaglandin F1